Amicus Therapeutics, Inc. Stock
Stocks
FOLD
US03152W1099
Biotechnology & Medical Research
|
Delayed
Nasdaq
06:00:00 25/04/26 am AEST
|
5-day change | 1st Jan Change | ||
| 14.49 USD | +0.21% |
|
-.--% | +1.76% |
| 06/05 | BioMarin Enters 'Transition Year' as Enzyme Portfolio Expands After Amicus Deal, Morgan Stanley Says | MT |
| 29/04 | Amicus Therapeutics, Inc.(NasdaqGM:FOLD) dropped from S&P Global BMI Index | CI |
| Market Cap | 4.55B 3.91B 3.69B 3.36B 6.29B 435B 6.34B 43.97B 16.92B 221B 17.09B 16.71B 701B | P/E 2024 |
-51.1x | P/E 2025 | -162x |
|---|---|---|---|---|---|
| Enterprise Value | 4.7B 4.04B 3.81B 3.47B 6.49B 449B 6.55B 45.41B 17.48B 228B 17.64B 17.26B 724B | EV / Sales 2024 |
5.69x | EV / Sales 2025 | 7.18x |
| Free-Float |
99.31% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript : Amicus Therapeutics, Inc.
| 1 day | +0.21% | ||
| 6 months | +0.91% | ||
| Current year | +1.76% |
| Current year | 14.2 |  | 14.5 |
| 1 year | 7.61 | | 14.5 |
| 3 years | 5.51 | | 14.57 |
| 5 years | 5.51 | | 14.57 |
| 10 years | 4.41 | | 25.39 |
| Manager | Title | Age | Since |
|---|---|---|---|
George Davis
PSD | President | 55 | 27/04/2026 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 27/4/26 | Issuer sale | General Counsel | 1,264,993 | 0.4029% | ||
| 27/4/26 | Issuer sale | Director | 395,940 | 0.1261% | ||
| 27/4/26 | Issuer sale | Chairman | 419,487 | 0.1336% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.21% | -.--% | +82.49% | +15.27% | 4.55B | |
| -0.69% | -6.21% | -4.73% | +9.20% | 46.05B | |
| -2.62% | -4.50% | +333.74% | +510.16% | 43.59B | |
| +0.42% | -3.34% | +35.73% | +20.19% | 42.35B | |
| +0.75% | -3.62% | +2.86% | +65.01% | 38.86B | |
| -1.44% | -4.76% | +10.26% | +38.52% | 32.24B | |
| +0.00% | -3.66% | - | - | 17.16B | |
| +1.53% | +0.02% | +18.86% | +111.71% | 16.28B | |
| +0.31% | -2.15% | +11.19% | +31.34% | 14.32B | |
| +2.21% | -3.72% | +73.88% | +39.12% | 13.03B | |
| Average | +0.08% | -4.26% | +62.70% | +93.39% | 26.84B | |
| Weighted average by Cap. | -0.31% | -5.01% | +71.99% | +119.91% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 528M 454M 429M 391M 730M 50.51B 737M 5.11B 1.96B 25.62B 1.98B 1.94B 81.37B | 634M 545M 515M 469M 876M 60.64B 884M 6.13B 2.36B 30.76B 2.38B 2.33B 97.69B |
| Net income | -56.11M -48.25M -45.53M -41.47M -77.53M -5.36B -78.23M -542M -209M -2.72B -211M -206M -8.64B | -27.11M -23.31M -22M -20.04M -37.46M -2.59B -37.8M -262M -101M -1.31B -102M -99.58M -4.18B |
| Net Debt | 194M 167M 157M 143M 268M 18.52B 270M 1.87B 720M 9.39B 727M 711M 29.84B | 149M 128M 121M 110M 206M 14.23B 208M 1.44B 554M 7.22B 559M 547M 22.92B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- FOLD Stock
Select your edition
All financial news and data tailored to specific country editions
